NFKB1 and Alzheimer disease: Chronic neuroinflammatory processes mediated by NF-κB significantly contribute to the initiation and progression of neuronal damage observed in AD and PD, thus making selective targeting of NF-κB an attractive therapeutic strategy (119, 120).